✦ LIBER ✦

P-289 Effect of low-dose cytarabine and aclarubicin in combination with decitabine on the outcome of patients with high-risk myelodysplastic syndromes

✍ Scribed by Pian, S.; Duan, L.; Zhu, Y.; Hong, M.; Zhang, R.; Zhang, S.; Liu, P.; Lu, H.; Wu, H.; Qiu, H.; Li, J.

Book ID: 123331474
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 91 KB
Volume: 37
Category: Article
ISSN: 0145-2126
DOI: 10.1016/S0145-2126(13)70336-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination of vorinostat and low dose c

Combination of vorinostat and low dose cytarabine for patients with azacitidine-refractory/relapsed high risk myelodysplastic syndromes

✍ Prebet, Thomas; Braun, Thorsten; Beyne-Rauzy, Odile; Dreyfus, Francois; Stammato 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 443 KB

Quantification of outpatient management

Quantification of outpatient management and hospitalization of patients with high-risk myelodysplastic syndrome treated with low-dose decitabine

✍ J. A. Pitako; P. S. Haas; J. Van den Bosch; H. Müller-Berndorff; A. Kündgen; U. 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 114 KB

The effect of decitabine dose modificati

The effect of decitabine dose modification and myelosuppression on response and survival in patients with myelodysplastic syndromes

✍ Jabbour, Elias; Garcia-Manero, Guillermo; Cornelison, A. Megan; Cortes, Jorge E. 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 264 KB

Effect of low-dose cytarabine and aclaru

Effect of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming (CAG regimen) on the outcome of elderly patients with acute myeloid leukemia

✍ Si-Xuan Qian; Jian-Yong Li; Tian Tian; Yun-Feng Shen; Yuan-Qiang Jiang; Hua Lu; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 219 KB

Bortezomib combined with low-dose cytara

Bortezomib combined with low-dose cytarabine in Intermediate-2 and high risk myelodysplastic syndromes. A phase I/II Study by the GFM

✍ Shanti Natarajan-Amé; Sophie Park; Lionel Ades; Norbert Vey; Agnès Guerci-Bresle 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

A combination chemotherapy with low dose

A combination chemotherapy with low doses of cytarabine and etoposide for high risk myelodysplastic syndromes and their leukemic stage: A pilot study

✍ Shin-ichiro Kuriya; Kazunori Murai; Yasuro Miyairi; Taiju Utsugisawa; Yasushi Na 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 2 views

## BACKGROUND. Even now, no definitely effective therapy is inducted to high risk myelodysplastic syndromes (MDS) and their leukemic stage (MDS-AML) except bone marrow transplantation. ## METHODS. Ten patients with high risk MDS and 6 with MDS-AML were treated with daily low doses of cytarabine